Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Hikma Resumes Launch Of Advair Rival
Follows FDA Approval Of ANDA Amendment That Forced Pause
Apr 21 2021
•
By
David Wallace
Hikma has restarted launch activities for its generic version of Advair • Source: Alamy
More from Products
More from Generics Bulletin